Abstract

Diarrhea in foals is a problem of significant clinical and economic consequence, and there are good reasons to believe microbiota manipulation can play an important role in its management. However, given the dynamic development of the foal microbiota and its importance in health and disease, any prophylactic or therapeutic efforts to alter its composition should be evidence based. The few clinical trials of probiotic preparations conducted in foals to date show underwhelming evidence of efficacy and a demonstrated potential to aggravate rather than mitigate diarrhea. Furthermore, recent studies have affirmed that variable but universally inadequate quality control of probiotics enables inadvertent administration of toxin-producing or otherwise pathogenic bacterial strains, as well as strains bearing transferrable antimicrobial resistance genes. Consequently, it seems advisable to approach probiotic therapy in particular with caution for the time being. While prebiotics show initial promise, an even greater scarcity of clinical trials makes it impossible to weigh the pros and cons of their use. Advancing technology will surely continue to enable more detailed and accurate mapping of the equine adult and juvenile microbiota and potentially elucidate the complexities of causation in dysbiosis and disease. In the meantime, fecal microbiota transplantation may be an attractive therapeutic shortcut, allowing practitioners to reconstruct a healthy microbiota even without fully understanding its constitution.

Highlights

  • Diarrhea affects more than 50–60% of foals in the first six months of life [1,2] and bears significant health and economic consequences

  • Supplementation had no significant impact on fecal microbiota composition, but microbial profiles at the conclusion of the study were more similar in treated foals, suggesting probiotic administration may have resulted in selection of certain bacteria

  • Encouraging results and applications of gut microbiota manipulation in other species have generated considerable interest in the use of such methods to confer enteric protection and manage diarrhea in foals. Both gastrointestinal tract (GIT) function and gut microbiota composition differ markedly in horses from those of the most studied subjects, which likely explains why cross-species efficacy has proved frustratingly elusive in equine studies

Read more

Summary

Introduction

Diarrhea affects more than 50–60% of foals in the first six months of life [1,2] and bears significant health and economic consequences. A 2020 Mach et al, study of the microbiota–gut–brain axis goes further and links variations in the microbiome of performance horses with stress, behavioral issues, performance and general welfare [8]. While this particular study focused on adult horses, it adds weight to a broader understanding of the importance of GIT microbiota in equine health and well-being. Microbiota manipulation for prophylactic or therapeutic management of foal diarrhea should not be abandoned, but more research is needed for such therapy to be deemed either effective or safe

Gut Microbiota Complexity in Horses
Singularity of the Developing Foal Microbiota
Causes and Consequences of Diarrhea in Foals
The Appeal of Microbiota Manipulation
Equine Probiotic Strains
The Evolution of Probiotic Studies in Foals
Study Limitations
Safety of Probiotics
Prebiotic Use in Horses and Foals
10. Fecal Microbiota Transplantation
11. Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call